conversational AI and persistent memory — delivering intelligent, context-aware engagement at scale.

The platform supports use cases ranging from clinical intake and RPM, to decentralized trials, industrial IoT monitoring, elite sports coaching, and mental wellness. Each AI agent interprets real-world signals — such as vitals, emotional tone, or machine state — and responds with structured, protocol-aligned actions.

MetaBrain Labs has reached this point through lean, founder-led execution, organically developing the technology, securing early customer adoption, and building a strong IP moat — anchored by U.S. Patent No. 11,996,179 B2. The company is now raising debt financing to support an IP licensing campaign and fund operational scale.